Literature DB >> 23607683

Exploring in-hospital death from myocardial infarction in Eastern Europe: from the International Registry of Acute Coronary Syndromes in Transitional Countries (ISACS-TC); on the Behalf of the Working Group on Coronary Pathophysiology & Microcirculation of the European Society of Cardiology.

Raffaele Bugiardini, Olivia Manfrini, Marta Majstorović Stakić, Edina Cenko, Sergei Boytsov, Bela Merkely, David Becker, Mirza Dilic, Zorana Vasiljevic, Akos Koller, Lina Badimon1.   

Abstract

INTRODUCTION: The aim of the current study was to investigate the outcomes of coronary reperfusion therapies and ST-segment elevation myocardial infarction (STEMI) in patients of Eastern countries with economies in transition. Federation, and Serbia. The overall population consisted of 23,486 consecutive patients admitted to hospitals from January 1(st) to December 31(st) 2009. Registry data and statistics from the Organization for Economic Cooperation and Development (OECD) countries for the same period were used for comparison (2009-2010). In-hospital mortality was between 4% and 5% in the Western countries. In comparison mortality data were significantly larger in Serbia (10.8%) and Bosnia and Herzegovina (11.2%), intermediate in Russian Federation (7.2%) and similar in Hungary (5.0%). The rates of primary percutaneous coronary intervention (primary PCI) were very low in Bosnia and Herzegovina (18.3%), low in Russian Federation (20.6%) and Serbia (22%), and high in Hungary (70%). Major risk factors for death appear to be lack of reperfusion therapy, longer time delay from symptoms onset to hospital presentation as well as the higher percentage of patients with clinical presentation in Killip class III/IV.
CONCLUSION: In-hospital STEMI case-fatality rates ranges widely in the former Eastern Bloc countries. Beyond the quality of care provided in hospitals, differences in time delay from symptoms onset to hospital admission may strongly influence STEMI patients' outcome.

Entities:  

Mesh:

Year:  2014        PMID: 23607683     DOI: 10.2174/157016111206141210122150

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  5 in total

1.  Sex-related differences of invasive therapy in patients with aneurysmal subarachnoid hemorrhage.

Authors:  S Y Bögli; D Utebay; N Smits; L P Westphal; L Hirsbrunner; S Unseld; E Keller; G Brandi
Journal:  Acta Neurochir (Wien)       Date:  2022-08-19       Impact factor: 2.816

2.  Association of major cardiovascular risk factors with the development of acute coronary syndrome in Lithuania.

Authors:  Indrė Čeponienė; Diana Žaliaduonytė-Pekšienė; Olivija Gustienė; Abdonas Tamošiūnas; Remigijus Žaliūnas
Journal:  Eur Heart J Suppl       Date:  2014-01       Impact factor: 1.803

Review 3.  Antithrombotic treatment tailoring and risk score evaluation in elderly patients diagnosed with an acute coronary syndrome.

Authors:  Alexandru Nicolae Mischie; Catalina Liliana Andrei; Crina Sinescu; Gani Bajraktari; Eugen Ivan; Georgios Nikolaos Chatziathanasiou; Michele Schiariti
Journal:  J Geriatr Cardiol       Date:  2017-07       Impact factor: 3.327

4.  Coronary heart disease incidence and competing risks: an important issue.

Authors:  Paolo Emilio Puddu; Peter Louis Amaduzzi; Beatrice Ricci
Journal:  J Geriatr Cardiol       Date:  2017-07       Impact factor: 3.327

Review 5.  Update on pharmacological treatment of acute coronary syndrome without persistent ST segment elevation myocardial infarction in the elderly.

Authors:  Coşkun Usta; Aslı Bedel
Journal:  J Geriatr Cardiol       Date:  2017-07       Impact factor: 3.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.